HA
ABBV icon

Halsey Associates’s AbbVie ABBV Stock Holding History

Halsey Associates’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$1.27M Buy
16,792
+3,861
+30% +$265K 0.2% 59
2019
Q2 		$940K Sell
12,931
-3,756
-23% -$295K 0.17% 62
2019
Q1 		$1.34M Sell
16,687
-1,462
-8% -$120K 0.22% 56
2018
Q4 		$1.67M Buy
18,149
+3,756
+26% +$330K 0.32% 52
2018
Q3 		$1.36M Sell
14,393
-700
-5% -$66.4K 0.24% 54
2018
Q2 		$1.4M Sell
15,093
-3,756
-20% -$367K 0.27% 51
2018
Q1 		$1.78M Hold
18,849
– – 0.31% 53
2017
Q4 		$1.82M Buy
18,849
+3,593
+24% +$339K 0.31% 52
2017
Q3 		$1.36M Hold
15,256
– – 0.27% 53
2017
Q2 		$1.11M Hold
15,256
– – 0.23% 56
2017
Q1 		$994K Sell
15,256
-200
-1% -$12.6K 0.21% 57
2016
Q4 		$968K Hold
15,456
– – 0.22% 59
2016
Q3 		$975K Sell
15,456
-416
-3% -$26.9K 0.21% 59
2016
Q2 		$983K Sell
15,872
-500
-3% -$30.5K 0.22% 60
2016
Q1 		$935K Sell
16,372
-350
-2% -$19.5K 0.21% 59
2015
Q4 		$991K Sell
16,722
-150
-0.9% -$8.64K 0.23% 60
2015
Q3 		$918K Hold
16,872
– – 0.22% 61
2015
Q2 		$1.13M Sell
16,872
-350
-2% -$22.8K 0.25% 57
2015
Q1 		$1.01M Buy
17,222
+689
+4% +$41.6K 0.22% 58
2014
Q4 		$1.08M Sell
16,533
-38
-0.2% -$2.4K 0.24% 59
2014
Q3 		$957K Sell
16,571
-9,843
-37% -$546K 0.22% 63
2014
Q2 		$1.49M Hold
26,414
– – 0.33% 52
2014
Q1 		$1.36M Buy
26,414
+500
+2% +$25.3K 0.31% 55
2013
Q4 		$1.37M Hold
25,914
– – 0.31% 56
2013
Q3 		$1.16M Sell
25,914
-800
-3% -$35.5K 0.28% 58
2013
Q2 		$1.1M Buy
+26,714
New +$1.17M 0.28% 58

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Halsey Associates's ABBV Position: Q3 2019 in Review

Halsey Associates increased its AbbVie (ABBV) stake by 30% in Q3 2019, buying an estimated $265K and bringing the position to 16,792 shares worth $1.27M. The position accounts for 0.2% of the portfolio, ranked #59.

Halsey Associates first reported a position in ABBV in Q2 2013 and has held it in 26 quarters since. The position peaked at $1.82M in Q4 2017. 2,002 funds tracked by Wall St. Rank hold ABBV as of Q3 2019.

  • Halsey Associates held 16,792 shares of AbbVie worth $1.27M as of Q3 2019.
  • Halsey Associates bought 3,861 AbbVie shares in Q3 2019, an estimated $265K.
  • AbbVie made up 0.2% of Halsey Associates's portfolio in Q3 2019, its #59 holding.
  • Halsey Associates first reported a position in AbbVie in Q2 2013 and has held it in 26 quarters since.
  • Halsey Associates's AbbVie position peaked at $1.82M in Q4 2017.
  • 2,002 funds tracked by Wall St. Rank held AbbVie as of Q3 2019.

Based on Halsey Associates's 13F filing for Q3 2019, filed 15 Nov 2019.